Alert icon

To align with industry best practices for security and data integrity, Project Data Sphere is requiring users to upgrade their browsers to one that supports encryption protocol TLS 1.2 by December 15, 2017. On that date, Project Data Sphere will disable support of browsers that permit SSL 3.0/TLS 1.0. To prevent any disruption to your access to Project Data Sphere, you must take action.
This browser was not recognized and may not be compatible with TLS 1.2 or higher. Please check with the browser's developer to confirm.
To view information about this, please visit the FAQ. If you have any further questions, please contact us.

Back to the List
Type(s) of Cancer
CNS
Study Phase
Phase 3
Study Completion Date
1992
NCT03015701Uploaded 07-26-2017
Access via NCI by Request
PDS UID: nci-data-364
N/A
Provider Information
Provider Data DescriptionNCT03015701-D3-Dataset.csv provides adverse event data from both the blinded and open label treatment epochs.
SponsorSouthwest Oncology Group
Data ProviderNational Cancer Institute
Clinical Trials.gov Information
Brief SummaryN/A
ConditionsN/A
Intervention TypeDrug, Placebo
Drug(s)N/A
Total EnrolledN/A
RandomizationN/A
Blinding MethodN/A
Arms InterventionN/A
Secondary IDN/A
PubMed (PMID)N/A
Collaborator(s)N/A
Region(s)N/A
Age RangeN/A
Files: NCT03015701-D3
Data DictionaryNCT03015701-D3-Data-Dictionary.pdf
DATANCT03015701-D3-Dataset.csv
OTHERREADME.pdf
Files: NCT03015701-D2
Data DictionaryNCT03015701-D2-Data-Dictionary.pdf
DATANCT03015701-D2-Dataset.csv
OTHERREADME.pdf
Files: NCT03015701-D1
Data DictionaryNCT03015701-D1-Data-Dictionary.pdf
DATANCT03015701-D1-Dataset.csv
OTHERREADME.pdf
© 2023 Project Data Sphere
All rights reserved
Privacy PolicyTerms of Use